Format

Send to

Choose Destination
  • Filters activated: Field: Title Word. Clear all
Molecules. 2018 Jan 18;23(1). pii: E201. doi: 10.3390/molecules23010201.

Liposomal TriCurin, A Synergistic Combination of Curcumin, Epicatechin Gallate and Resveratrol, Repolarizes Tumor-Associated Microglia/Macrophages, and Eliminates Glioblastoma (GBM) and GBM Stem Cells.

Author information

1
Ph.D. Program in Biochemistry, The Graduate Center, City University of New York, New York, NY 10016, USA. smukherjee@gradcenter.cuny.edu.
2
Department of Chemistry, City University of New York, The College of Staten Island, Staten Island, NY 10314, USA. smukherjee@gradcenter.cuny.edu.
3
Ph.D. Program in Biochemistry, The Graduate Center, City University of New York, New York, NY 10016, USA. Juliet.Baidoo@csi.cuny.edu.
4
College of Arts and Science, New York University, New York, NY 10003, USA. samay.sampat@gmail.com.
5
Ph.D. Program in Biochemistry, The Graduate Center, City University of New York, New York, NY 10016, USA. Andrew.Mancuso@csi.cuny.edu.
6
Department of Chemistry, City University of New York, The College of Staten Island, Staten Island, NY 10314, USA. Andrew.Mancuso@csi.cuny.edu.
7
Center for Developmental Neuroscience, City University of New York, The College of Staten Island, Staten Island, NY 10314, USA. lovenagrace@yahoo.com.
8
Department of Chemistry, City University of New York, The College of Staten Island, Staten Island, NY 10314, USA. Leah.Cohen@csi.cuny.edu.
9
Department of Chemistry, City University of New York, The College of Staten Island, Staten Island, NY 10314, USA. Shuiqin.Zhou@csi.cuny.edu.
10
Department of Chemistry, City University of New York, The College of Staten Island, Staten Island, NY 10314, USA. probal.banerjee@csi.cuny.edu.
11
Center for Developmental Neuroscience, City University of New York, The College of Staten Island, Staten Island, NY 10314, USA. probal.banerjee@csi.cuny.edu.

Abstract

Glioblastoma (GBM) is a deadly brain tumor with a current mean survival of 12-15 months. Despite being a potent anti-cancer agent, the turmeric ingredient curcumin (C) has limited anti-tumor efficacy in vivo due to its low bioavailability. We have reported earlier a strategy involving the use two other polyphenols, epicatechin gallate (E) from green tea and resveratrol (R) from red grapes at a unique, synergistic molar ratio with C (C:E:R: 4:1:12.5, termed TriCurin) to achieve superior potency against HPV+ tumors than C alone at C:E:R (μM): 32:8:100 (termed 32 μM+ TriCurin). We have now prepared liposomal TriCurin (TrLp) and demonstrated that TrLp boosts activated p53 in cultured GL261 mouse GBM cells to trigger apoptosis of GBM and GBM stem cells in vitro. TrLp administration into mice yielded a stable plasma concentration of 210 nM C for 60 min, which, though sub-lethal for cultured GL261 cells, was able to cause repolarization of M2-like tumor (GBM)-associated microglia/macrophages to the tumoricidal M1-like phenotype and intra-GBM recruitment of activated natural killer cells. The intratumor presence of such tumoricidal immune cells was associated with concomitant suppression of tumor-load, and apoptosis of GBM and GBM stem cells. Thus, TrLp is a potential onco-immunotherapeutic agent against GBM tumors.

KEYWORDS:

GBM stem cells; NK cells; TriCurin; curcumin; epicatechin gallate; glioblastoma multiforme (GBM); liposomes; resveratrol; tumor-associated microglia/macrophages (TAM)

PMID:
29346317
PMCID:
PMC6017476
DOI:
10.3390/molecules23010201
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

Probal Banerjee has a pending patent application “Activity Enhancing Curcumin Compositions and Methods of Use”, PCT/US14/67819. The remaining authors declare no conflict of interest.

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center